A/H5N1/LT Dose Ranging Study

Clinical trial NCT00908687 · COMPLETED

Trial details

NCT number: NCT00908687
Sponsor: Intercell USA, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pandemic Influenza

Start date: 2009-05-01
Primary completion: 2010-01-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.